HealthEquity Reports First Quarter Ended April 30, 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
HealthEquity, Inc (HQY) PT Raised to $57 at Chardan Capital Markets; 'Strong Execution'
June 7, 2017 6:04 AM EDTChardan Capital Markets raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $57.00 (from $53.00) while maintaining a Buy rating.
Analyst Steven Wardell notes Q1 adj. EBITDA was in-line with expectations and a 1% topline beat driven by strong performance in the Custodial revenue.... More
HealthEquity (HQY) Tops Q1 EPS by 7c; Raises Outlook
June 6, 2017 4:10 PM EDTHealthEquity (NASDAQ: HQY) reported Q1 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $55.4 million versus the consensus estimate of $54.77 million.
GUIDANCE:
HealthEquity sees FY2018 EPS of $0.62-$0.67, versus the consensus of $0.53. HealthEquity sees... More
